| Literature DB >> 35268802 |
Tânia Laranjeira1, Ana Costa2, Catarina Faria-Silva2, Daniela Ribeiro3,4, José Miguel P Ferreira de Oliveira3, Sandra Simões2, Andreia Ascenso2.
Abstract
Tomato producing and processing industries present undoubted potential for industrial discarded products valorization whether due to the overproduction of fresh tomatoes or to the loss during processing. Although tomato by-products are not yet considered a raw material, several studies have suggested innovative and profitable applications. It is often referred to as "tomato pomace" and is quite rich in a variety of bioactive compounds. Lycopene, vitamin C, β-carotene, phenolic compounds, and tocopherol are some of the bioactives herein discussed. Tomato by-products are also rich in minerals. Many of these compounds are powerful antioxidants with anti-inflammatory properties besides modulating the immune system. Several researchers have focused on the possible application of natural ingredients, especially those extracted from foods, and their physiological and pharmacological effects. Herein, the effects of processing and further applications of the bioactive compounds present in tomato by-products were carefully reviewed, especially regarding the anti-inflammatory and anti-cancer effects. The aim of this review was thus to highlight the existing opportunities to create profitable and innovative applications for tomato by-products in health context.Entities:
Keywords: anti-cancer; anti-inflammatory; oleoresins; peel; pomace; seeds; tomato; tomato processing industry
Mesh:
Year: 2022 PMID: 35268802 PMCID: PMC8911995 DOI: 10.3390/molecules27051701
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Advantages and Disadvantages of tomatoes processing [18].
| Advantages | Disadvantages |
|---|---|
| Extended food lifespan and storage period | Not fresh and with preservatives |
| Consumption out of season and a more diversified diet | More caloric than fresh tomatoes |
| Facilitated food storage | Decreased specific bioactive content (e.g., thermolabile molecules as vitamins) unlike others (e.g., |
| Higher stability | More expensive to consumers |
| Decreased tomato losses | |
| Increased market value of tomatoes |
Figure 1Graphic representation of estimated percentages of tomato processed by-products by USDA [20].
Figure 2Chemical structure of main bioactives extracted from tomato by-products: (a) vitamin C; (b) vitamin E; (c) lycopene; (d) β-carotene.
Figure 3Schematic representation of the main mode of action of lycopene as anti-inflammatory and anti-cancer agent.
Clinical studies to assess the anti-inflammatory properties of lycopene.
| Supplements/Diet | Dose | Study | Outcomes/Observed Effect | Reference |
|---|---|---|---|---|
| Lycopene in soft gel capsules | 10 mg lycopene/day, 8 weeks | Patients with erosive oral lichen planus recalcitrant to topical steroids | Higher reduction of the 8-isoprostane levels (biomarker of lipid peroxidation and oxidative stress) in the group treated with lycopene | [ |
| Lycopene supplements | 4 mg lycopene/day, 8 weeks | 13 patients with symptomatic oral lichen planus | 11 patients showed a partial remission of the lesion; a complete remission was observed in 2 patients. | [ |
| Tomato paste | 16 mg lycopene/day, 10 weeks | 22 participants, type II skin, UV light at dorsal skin | Significant reduction of erythema. | [ |
| Lycopene softgel capsule | 8 mg lycopene/day, 12 weeks | 24 participants, type II skin, UV light at dorsal skin | Significant reduction of erythema. | [ |
| Tomato paste | 16 mg lycopene/day, 12 weeks | 20 participants, type I or II skin, UV light at upper buttock skin | Significant increase in the minimal UV dose required to cause erythema; inhibition of MMP-1 expression induced by UV. | [ |
| Lycopene softgel capsule | 20 mg lycopene/day, 12 weeks | 33 participants, UV light at upper buttock skin | Inhibition of HO-1, MMP-1 and ICAM-1 expression induced by UV. | [ |
| Supplements of tomato extract | 11 mg lycopene, phytoene, and phytofluene, 4 weeks | 20 participants (endurance runners) | No significant differences were observed in the oxidative stress and inflammation after exercise. | [ |
| Lycopene supplements (form of lactolycopene and lycosome-formulated GA lycopene) | 7 mg lycopene/day, 30 days | 69 patients with coronary vascular disease supplemented with a daily dose of lycopene in the form of lactolycopene;74 patients supplemented with the form of lycosome-formulated GA lycopene | Reduction of | [ |
| Tomato juice | tomato juice (500 mL/day), 4 weeks | 57 patients with type 2 diabetes | Consumption of tomato juice increased the resistance of LDL to oxidation. | [ |
Clinical studies to assess the anti-cancer properties of lycopene.
| Supplements/Diet | Dose | Study | Outcomes/Observed Effect | Reference |
|---|---|---|---|---|
| Tomato lycopene extract | 30 mg lycopene/day, 10 ± 2 days | Colon cancer patients | Reduction in 25% of insulin-like growth factor (IGF)-1 in plasma of the patients. | [ |
| Tomato-derived lycopene | 30 mg lycopene/day, 8 weeks | 40 men and 31 postmenopausal women with: a personal history of colorectal adenoma; a family history of colorectal cancer; and both situations | The concentration of IGFBP-1 increased in women after lycopene supplementation;The level of IGFBP-2 at serum increased in women and men after lycopene supplementation. | [ |
| Lycopene from tomato oleoresin embedded in whey protein matrix | 20 mg/day, duration of the treatment | 28 patients with metastatic colorectal cancer (13 also treated with lycopene) | Reduction of skin toxicity induced by treatment; decrease of the mean malondialdehyde index | [ |
| Lycopene supplementation | 15 mg lycopene twice daily, 3 weeks | Phase II clinical trial:26 men with newly diagnosed prostate cancer | The levels of plasma PSA decreased by 18% in the group treated with lycopene supplementation, but increased in 14% for the control group; the expression of Cx43 was 0.63 and 0.25 in supplementation and control group, respectively. | [ |
| Lycopene as tomato sauce-based pasta dishes | 30 mg lycopene/day, 3 weeks | 60 men with adenocarcinoma of the prostate | After the consumption of tomato sauce, the level of PSA and leukocyte DNA 8-OH-deoxyguanosine/deoxyguanosine (marker of DNA damage) decreased in 17.5% and 21.3% in comparison with control group, respectively; the apoptotic index increased in the hyperplastic and neoplastic of the resected tissue | [ |
| Tomato products and tomato products combined with other nutritional substances (selenium, omega-3 fatty acids, soy isoflavones, grape/pomegranate juice, and green/black tea) | 30 mg lycopene/day, 3 weeks | 79 patients with prostate cancer | Median PSA decreased in 2.9% in the tomato group as compared with control diet; the largest reduction in PSA was observed in patients who had the highest increase of lycopene, selenium and C20:5 | [ |
| Tomato-derived lycopene supplementation | 30 mg lycopene/day, 2 months | Premenopausal women: 24 with history of breast cancer and 36 with family history of breast cancer | Lycopene supplementation did not change the level of total serum IGF-1 in both populations of the study; in breast cancer survivors, the levels of IGF-1 and IGFBP-3 increased; for the population with high-risk of breast cancer, the levels of free IGF-1 decreased after supplementation. | [ |
| Tomato juice | 160 g juice/day, 6 months | 23 patients with breast cancer subjected to radiotherapy | Serum lycopene concentrations significantly increased from end of radiotherapy to final period of consumption of tomato juice (~0.3 to 0.8 µmol/L); skin moisture increased; no change in urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels was observed; however, there was negative correlation between lycopene and 8-OHdG levels. | [ |
| Various food products (questionnaire, epidemiological study) | variable | 123,570 participants, 3978 cases of squamous cell carcinoma. | Higher intakes of lycopene were significantly associated with decreased risk of squamous cell carcinoma. | [ |
Insulin-like growth factor (IGF-1); Insulin-like growth factor binding proteins (IGFBPs).
Figure 4Schematic representation of traditional tomato production and processing circuit versus added-value circuit.